Do you have the same question? Follow this Question
Oct 01, 2025 - 04:58 AM
We’ve provided several answers to questions related to Amrix (Cyclobenzaprine Hydrochloride Extended-Release Capsules) , see some other helpful Q&A related to this product.
Question: What is the MedlinePlus identifier for this product?
Answer: The MedlinePlus identifier is a682514. MedlinePlus provides reliable, up-to-date information about medications, which is essential for patient education and informed decision-making.
Question: What is the bioavailability of this product?
Answer: The bioavailability ranges from 33-55%. Bioavailability refers to how much of the drug reaches the bloodstream, affecting its efficacy in providing relief from muscle spasms.
Question: What is the elimination half-life of the extended-release version of this product?
Answer: The elimination half-life of the extended-release version is up to 32 hours. This extended half-life allows for once-daily dosing, improving convenience and adherence to treatment.
Question: What is the active ingredient in this product?
Answer: The active ingredient is cyclobenzaprine. Cyclobenzaprine is valuable for its muscle relaxant properties, which help relieve muscle spasms associated with painful musculoskeletal conditions.
Question: What is the KEGG identifier for this product?
Answer: The KEGG identifier is D00346. The KEGG database provides a reference for understanding drug interactions and pathways, which can be valuable in clinical research and treatment planning.
View all Amrix (Cyclobenzaprine Hydrochloride Extended-Release Capsules) Questions & Answers
